StockData
Edwards Lifesciences Corp logo

Edwards Lifesciences Corp (EW) stock

EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3057% above fair value
$105.80−0.01 (-0.01%)

Close on Nov 12, 2026Market cap $60.98BP/E 59.8Yield –

Edwards Lifesciences EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Edwards Lifesciences's EV/EBITDA was 35.6× on Nov 11, 2026, against 29.8× a year earlier. Over the last 5 years it ranged from 24.3× to 44.2×, with a median of 30.2×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202635.6×+6.4
2025Dec 31, 202529.2×+3.7
2024Dec 31, 202425.5×−7.6
2023Dec 29, 202333.1×+8.3
2022Dec 30, 202224.9×−19.3
2021Dec 31, 202144.2×−14.5
2020Dec 31, 202058.7×+6.5
2019Dec 31, 201952.3×+25.2
2018Dec 31, 201827.1×+3.8
2017Dec 29, 201723.3×−1.9
2016Dec 30, 201625.2×+0.3
2015Dec 31, 201524.9×+14.1
2014Dec 31, 201410.8×−0.7
2013Dec 31, 201311.4×−14.3
2012Dec 31, 201225.7×+3.0
2011Dec 30, 201122.8×−5.3
2010Dec 31, 201028.1×+6.2
2009Dec 31, 200921.8×–

More Edwards Lifesciences figures

See a number that looks wrong?